Globally, significant resources and time are invested in researching new therapies that often fail clinically and benefit no patients. Envision a world where predicting a…
View More Why Many AI Drug Discovery Startups Face Challenges — and How Turbine Intends to Succeed
SugaROx, an agri-biotech spinout in Oxford, has raised an additional €1.1 million (£1 million) in a seed round extension to advance its crop-enhancing biostimulant. The…
View More SugaROx of Oxford Raises €1.1 Million to Boost Biostimulant Production
Norrsken Foundation has introduced Norrsken Evolve, a new €57 million pre-seed fund designed to support startups at the crossroads of impact, resilience, and scalability. The…
View More Norrsken Evolve Unveils €57M Fund to Support “Impact Tech”
Tiba Biotech, a targeted recipient, had a $750,000 contract with BARDA set to end on October 30. They were developing an RNAi-based therapeutic for H1N1…
View More RFK Jr. Backs mRNA Research, But Not for Vaccines
In a crucial time for consumer-driven health, there’s a growing desire for personalized care, data-driven insights, and a heightened focus on longevity and preventative health,…
View More CoreVitals Aims at the Next Frontier in Preventative Health
Riga-based Cellbox Labs, a developer of miniature human organ replicas outside the body, has secured €3.3 million in non-dilutive funding to enhance its dynamic organ-on-a-chip…
View More Latvian BioTech Startup Cellbox Labs Secures €3.3 Million for Organ-on-Chip Innovation Eliminating Animal Testing
For decades, precision medicine has been an aspiration, aiming to tailor treatments to each patient’s unique biology. Thanks to advances in data generation and computational…
View More Precision Medicine Fulfills Its Promise with Profound Implications
Copenhagen-based SNIPR Biome, a BioTech company focused on microbial CRISPR-medicine, has closed a €35 million Series B round to further CRISPR-based therapies for cystic fibrosis…
View More Danish BioTech Scale-Up SNIPR Biome Secures €35 Million to Combat Antimicrobial Resistance in Diseases Such as Cancer
Madrid-based startup Orbital Paradigm has secured over €1.5 million in Pre-Seed funding to advance its reusable orbital re-entry capsules, addressing a significant challenge in space…
View More Spanish SpaceTech Orbital Paradigm Secures €1.5 Million to Develop Reusable Space Capsules
French MedTech developer Sanofi has completed its acquisition of Vigil Neuroscience, Inc., aiming to enhance its neurology pipeline with a new investigational medicine for Alzheimer’s…
View More Sanofi Completes Acquisition of Vigil Neuroscience to Enhance Alzheimer’s Treatment Pipeline